3. As of noon trading, Merck ( MRK) is up $0.56 (1.20) to $47.21 on average volume Thus far, 6.7 million shares of Merck exchanged hands as compared to its average daily volume of 16.3 million shares. The stock has ranged in price between $46.46-$47.24 after having opened the day at $46.75 as compared to the previous trading day's close of $46.65.

Merck & Co., Inc. provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products worldwide. Merck has a market cap of $139.4 billion and is part of the health care sector. The company has a P/E ratio of 23.6, above the S&P 500 P/E ratio of 17.7. Shares are up 13.9% year to date as of the close of trading on Tuesday. Currently there are 10 analysts that rate Merck a buy, 1 analyst rates it a sell, and 4 rate it a hold.

TheStreet Ratings rates Merck as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Merck Ratings Report now.

Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100%. See his top picks for 14-days FREE.

If you liked this article you might like

Bristol-Myers Squibb Stock Still a Beast?

There Are Good Opportunities in Stock Picking

Halozyme Jumps on Immuno-Oncology Deal with Bristol-Myers

Achillion Shares Are Plunging on Termination of Hepatitis C Pact